Author

Matteo Fornai 1

1 University of Pisa,Pisa,Italy

BASELINE IL-23 SERUM LEVELS PREDICT THERAPEUTIC RESPONSE TO USTEKINUMAB THERAPY IN CROHN'S DISEASE. A PROSPECTIVE STUDY

Lorenzo Bertani, Luca Antonioli, Marco Fornili, Vanessa D'Antongiovanni, Francesca Coppini, Ceccarelli Linda, Laura Benvenuti, Maria Gloria Mumolo, Laura Baglietto, Massimo Bellini, Matteo Fornai, Nicola De Bortoli, Francesco Costa

EFFECTS OF SACCHAROMYCES BOULARDII CNCM I-745 ON GUT DYSBIOSIS AND ALTERED EPITHELIAL BARRIER INTEGRITY IN A MURINE MODEL OF NONSTEROIDAL ANTI-INFLAMMATORY DRUG-INDUCED ENTEROPATHY

Vanessa D'Antongiovanni, Luca Antonioli, Laura Benvenuti, Carolina Pellegrini, Clelia Di Salvo, Marco Calvigioni, Adelaide Panattoni, Sebastiano Banni, Gianfranca Carta, Emilia Ghelardi, Matteo Fornai

Histomorphological and molecular characterization of Parkinson´s disease patients with chronic constipation: a pilot study

Massimo Bellini, Bernardo Fani, Lorenzo Bertani, Gabriele Bellini, Andrea Pancetti, Matteo Fornai, Chiara Ippolito, Daniela Frosini, Carolina Pellegrini, Dario Gambaccini, Nunzia Bernardini, Roberto Ceravolo, Santino Marchi, Corrado Blandizzi

PROTECTIVE EFFECTS OF SACCHAROMYCES BOULARDII CNCM I-745 AGAINST NONSTEROIDAL ANTI-INFLAMMATORY DRUG-INDUCED INTESTINAL INJURY

Laura Benvenuti, Luca Antonioli, Vanessa D'Antongiovanni, Carolina Pellegrini, Clelia Di Salvo, Larisa Ryskalin, Gianfranco Natale, Marco Calvigioni, Adelaide Panattoni, Emilia Ghelardi, Matteo Fornai

RIFAXIMIN PREVENTS ENTERIC BACTERIA ALTERATIONS AND INFLAMMATION IN A RAT MODEL OF DICLOFENAC-INDUCED ENTEROPATHY

Rocchina Colucci, Emilia Ghelardi, Erika Tirotta, Elena Piccoli, Deborah Sacco, Luca Antonioli, Matteo Fornai, Cecilia Renzulli, Carolina Pellegrini, Corrado Blandizzi, Carmelo Scarpignato

Item 1 - 5 / 5
1